The Effect of Perioperative β-blockade on the Pulmonary Function of Patients Undergoing Major Arterial Surgery

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 3, 2006, Pages 305-308

  Kieran, S M ^a   Cahill, R A ^a   Browne, I ^a   Sheehan, S J ^a   Mehigan, D ^a   Barry, M C ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Perioperative blockade; Perioperative cardiac risk; Peripheral arterial surgery; Peripheral vascular disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; SALBUTAMOL;

ADULT; AGED; ANAMNESIS; ARTERY DISEASE; ARTERY SURGERY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFORMED CONSENT; LUNG DISEASE; LUNG FUNCTION; MAJOR SURGERY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SPIROMETRY; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTRAOPERATIVE PERIOD; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; VASCULAR SURGICAL PROCEDURES;

EID: 33746934643     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.02.015     Document Type: Article

References (23)

1. London M., Zaugg M., Schaub M., and Spahn D. Perioperative beta-adrenergic receptor blockade. Anesthesiology 100 (2004) 170-175
2. Fleisher L., and Eagle K. Lowering cardiac risk in noncardiac surgery. N Engl J Med 345 23 (2003) 1677-1682
3. Wesorick D.H., and Eagle K.A. The preoperative cardiovascular evaluation of the intermediate-risk patient: new data, changing strategies. Am J Med 118 (2005) 1413.e1-1413.e9
4. Rapchuk I., Rabuka S., and Tonelli M. Perioperative use of beta-blockers remains low: experience of a single Canadian tertiary institution: [L'usage perioperatoire des beta-bloquants n'est pas frequent: l'experience d'un seul centre tertiaire canadien]. Can J Anaesth 51 8 (2004) 761-767
5. Egred M., Shaw S., Mohammad B., Waitt P., and Rodrigues E. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. QJM 98 (2005) 493-497
6. Lee D.K., Borade P.S., and Currie G.P. Safety of beta-blockers in COPD: the jury must still be out. QJM 98 (2005) 706-707
7. Weller J., and Karim Z. Perioperative beta-blockade: guidelines and practice in New Zealand. Anaesth Intensive Care 33 5 (2005) 645-650
8. European Respiratory Society. Standardised lung function testing. Official statement. Eur Respir J Suppl 16 (1993) 1-100
9. Borrill Z.L., Houghton C.M., Woodcock A.A., Vestbo J., and Singh D. Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol 59 (2005) 379-384
10. The GOLD Workshop Panel. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report (2001), National Heart, Lung, and Blood Institute, Bethseda, Md NIH publication No. 2701
11. Shammash J.B., Trost J.C., Gold J.M., Berlin J.A., Golden M.A., and Kimmel S.E. Perioperative β-blocker withdrawal and mortality in surgical patients. Am Heart J 141 (2001) 148-153
12. Auerbach A.D., and Goldman L. β-blockers and reduction of cardiac events in noncardiac surgery. JAMA 287 (2002) 1445-1447
13. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. New Engl J Med 341 (1999) 1789-1794
14. Siddiqui A.K., Ahmed S., Delbeau H., Conner D., and Mattana J. Lack of physician concordance with guidelines on the perioperative use of beta-blockers. Arch Intern Med 164 6 (2004) 664-667
15. Lindenauer P.K., Fitzgerald J., Hoople N., and Benjamin E.M. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med 164 7 (2004) 762-766
16. Fuso L., Cisternino L., Di Napoli A., Di Cosmo V., Tramaglino L.M., Spadaro S., et al. Role of spirometric and arterial gas data in predicting pulmonary complications after abdominal surgery. Respir Med 94 (2000) 1171-1176
17. Kispert J.F., Kazmers A., and Roitman L. Preoperative spirometry predicts perioperatrive pulmonary complications after major vascular surgery. Am Surg 58 8 (1992) 491-495
18. Camsari A., Arikan S., Avan C., Kaya D., Pekdemir H., Cicek D., et al. Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease. Heart Vessels 18 4 (2003) 188-192
19. Andrus M.R., Holloway K.P., and Clark D.B. Use of beta-blockers in patients with COPD. Ann Pharmacother 38 (2004) 142-145
20. Salpeter S., Ormiston T., and Salpeter E. Cardioselective blockers for reversible airway disease. Cochrane Database Syst Rev (2002) (1): CD002922
21. Salpeter S.S., Ormiston T., Salpeter E., Poole P., and Cates C. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) (2):CD003566
22. Barnett M.J., Milavetz G., and Kaboli P.J. β-blocker therapy in veterans with asthma or chronic obstructive pulmonary disease. Pharmacotherapy 25 (2005) 1550-1559
23. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137 9 (2002) 715-725